LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Powerful Tool Detects Fast-Spreading SARS-COV-2 Variants

By LabMedica International staff writers
Posted on 30 Jan 2025

Throughout the course of the COVID-19 pandemic, new variants of SARS-CoV-2 have emerged, each demonstrating increased transmissibility. Viruses can mutate in ways that enhance their ability to infect hosts, either by increasing viral load or evading immune responses. Rapid detection of these mutations is crucial to understanding viral biology and identifying new variants that may require further investigation. Quickly identifying mutations that contribute to higher transmission rates can aid in outbreak control and help spot potential immune escape variants. However, determining how individual mutations influence viral transmission has proven to be a difficult task. To overcome this challenge, researchers have developed a tool capable of detecting SARS-CoV-2 variants with high transmission potential before they become widespread.

A team of scientists, led by the Peter Doherty Institute for Infection and Immunity (Doherty Institute, Melbourne, Australia) and the University of Pittsburgh (Pittsburgh, PA, USA), analyzed millions of viral genome sequences from around the world. Their work revealed specific mutations that give SARS-CoV-2 a significant advantage in spreading. While many of these mutations were found in the virus’s spike protein, which is responsible for allowing the virus to enter human cells and is targeted by antibodies, the researchers also discovered important mutations in less-studied regions of the virus.


Image: The tool can detect SARS-CoV-2 variants having high transmission potential (Photo courtesy of 123RF)
Image: The tool can detect SARS-CoV-2 variants having high transmission potential (Photo courtesy of 123RF)

These mutations play a role in enhancing the virus's ability to bind to human cells, evade immune responses, or alter protein structure. Unlike previous methods, this new model, highlighted in Nature Communications, uses genomic surveillance data to accurately identify the mutations driving the spread of certain variants, even when these mutations appear in only a small fraction of cases. While the model was developed specifically for SARS-CoV-2, the researchers believe it can be adapted to track the transmission of other pathogens, such as influenza.

“Our method is like a magnifying glass for viral evolution, helping public health systems spot and monitor highly transmissible variants before they become widespread,” said Associate Professor John Barton from the University of Pittsburgh, co-lead author of the study. “Not only can we track SARS-CoV-2 more effectively, but our method can also be adapted to study the evolution of other pathogens, helping us stay ahead of future outbreaks. It’s a powerful tool for global efforts to tackle emerging diseases.”


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Ultrasonic Cleaner
UC 300 Series
New
Silver Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay

Latest Molecular Diagnostics News

Groundbreaking Molecular Diagnostic Test Accurately Diagnoses Major Genetic Cause of COPD

First-in-Class Diagnostic Blood Test Detects Axial Spondyloarthritis

New Molecular Label to Help Develop Simpler and Faster Tuberculosis Tests